Quest Diagnostics Inc. (DGX) Financials
Key financial figures for Quest Diagnostics Inc. (Q3 2026).
Quest Diagnostics Q3 2026 revenue rose 10.0% to $3.097 billion, adjusted EPS rose 15.4% to $3.00, and full-year revenue and EPS guidance was raised again. Net revenues were $3,097 million, up 10.0% from $2,816 million a year earlier; Diagnostic Information Services revenues rose 10.2% to $3,035 million. Requisition volume grew 14.5% (14.4% organic) while revenue per requisition fell 4.2%, the third straight year-over-year decline after -1.3% in Q1 and -2.8% in Q2 2026. Reported diluted EPS was $2.78, up 28.7% from $2.16; adjusted diluted EPS was $3.00, up 15.4% from $2.60. Reported operating income rose 24.2% to $479 million (15.5% of revenue versus 13.7%). On the outlook: Full-year 2026 net revenues raised to $12.065-$12.105 billion (prior $11.95-$12.05 billion), up 9.3% to 9.7%; reported diluted EPS raised to $10.21-$10.31 (prior $9.97-$10.17); adjusted diluted EPS raised to $11.25-$11.35 (prior $11.05-$11.25); cash provided by operations now approximately $1.90 billion (prior approximately $1.80 billion); capital expenditures unchanged at approximately $550 million. Figures are for Q3 2026, as Quest Diagnostics Incorporated reported them.
- Revenue
- $3.1B
- Net Income
- $312M
- EPS
- $2.82
- Total Assets
- $17.2B
- Operating Cash Flow
- $740M
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q3 FY2026 | $3.1B | $312M | $2.78 | 15.47% | $574M |
| Q2 FY2026 | $3.0B | $320M | $2.84 | 15.08% | $330M |
| Q1 FY2026 | $2.9B | $252M | $2.24 | 13.78% | $164M |
| Q4 FY2025 | $2.8B | $245M | $2.18 | 13.93% | $307M |
| Q3 FY2025 | $2.8B | $245M | $2.16 | 13.71% | $419M |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2025 | $11.0B | $992M | $8.75 | 14.53% | $1.4B |
| FY2024 | $9.9B | $871M | $7.69 | 13.63% | $909M |
| FY2023 | $9.3B | $854M | $7.49 | 13.64% | $864M |
Frequently asked questions
What was Quest Diagnostics Incorporated's revenue last quarter?
Quest Diagnostics Incorporated reported revenue of $3.10 billion for Q3 FY2026, up 10.0% from the same period a year earlier.
Is Quest Diagnostics Incorporated profitable?
Yes. Quest Diagnostics Incorporated reported net income of $312.0 million for Q3 FY2026, a net margin of 10.07% on revenue.
How has Quest Diagnostics Incorporated's margin trended?
Operating margin was 15.47% in Q3 FY2026, compared with 13.71% in the same period a year earlier. The quarter by quarter series is on the SentiSense financials page.
How much free cash flow did Quest Diagnostics Incorporated generate?
Quest Diagnostics Incorporated generated free cash flow of $574.0 million in Q3 FY2026, after capital expenditure.
Full income statement, balance sheet and cash flow for Quest Diagnostics Inc. on SentiSense, with up to forty quarters and twenty fiscal years of history.